Nonapeptide-1
Melanostatine-5, White 05
A synthetic nonapeptide that inhibits melanin synthesis by antagonizing the MC1R receptor, used in cosmetics for skin lightening and reducing hyperpigmentation.
Completed
PHASE3
NCT00105404
Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation
National Eye Institute (NEI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT05588778
Cognitive Enhancement and Risk-reduction Through Exercise for Brain-Related Outcomes
University of Illinois at Chicago
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
NCT05171491
LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
LungLife AI
OBSERVATIONAL
Updated Dec 15, 2025
Completed
NCT00106795
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID)
OBSERVATIONAL
Updated Dec 15, 2025
Unknown
NA
NCT05876702
Endoscopic I-scan Versus Histopathological Evaluation Of Esophageal Lesions
Sohag University
INTERVENTIONAL
Updated Dec 15, 2025
Withdrawn
PHASE2
NCT00120653
Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)
National Heart, Lung, and Blood Institute (NHLBI)
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE4
NCT06265259
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients
University of Thessaly
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT00501150
Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections
Imperial College London
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00570661
Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis
Italfarmaco
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT00379587
Rituximab for Prevention of Chronic GVHD
Dana-Farber Cancer Institute
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2, PHASE3
NCT02069899
A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody
Swedish Orphan Biovitrum
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT02246413
Research Aimed at Improving Both Mood and Weight
Palo Alto Medical Foundation
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT00094068
The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients
National Institutes of Health Clinical Center (CC)
OBSERVATIONAL
Updated Dec 15, 2025
Unknown
PHASE2
NCT03688958
Iodine Supplementation on Breast Cancer
Universidad Nacional Autonoma de Mexico
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT07024849
Developing an Ecological and Tailored Nutritional Intervention to Improve Quality of Life in Esophageal Cancer Survivors
Samsung Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01929434
Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis
General Hospital of Chinese Armed Police Forces
INTERVENTIONAL
Updated Dec 15, 2025
Not Yet Recruiting
NA
NCT07249034
Impact of Epilepsy on the Brainstem Adenosine Pathway and Its Relation With Arousal and Respiratory Reactivity
Hospices Civils de Lyon
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT05666622
DNI Values After Periodontal Treatment
Kahramanmaras Sutcu Imam University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT04076176
The Effects of CGMP in Children and Adults With PKU
Vitaflo International, Ltd
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT04880824
Analysis of Frailty Syndrome Within the Framework of the Innovation Fund Project PRÄP-GO (ANA-PRÄP-GO)
Charite University, Berlin, Germany
OBSERVATIONAL
Updated Dec 15, 2025